{"brief_title": "Schizophrenia Study In Adults", "brief_summary": "A Placebo Controlled Study For Patients With Schizophrenia", "condition": ["Schizophrenia"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["talnetant", "risperidone"], "criteria": "Inclusion Criteria: - Patient must meet diagnostic criteria for schizophrenia. Exclusion Criteria: - Patients with other psychotic disorders. - Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition. - Patients with a history of autistic disorder or another pervasive developmental disorder. - Patients with epilepsy or a history of seizures requiring treatment. - Patients who are excluded from taking the drug risperidone. - Patients who pose a current serious suicidal or homicidal risk. - Patients who are adequately stabilized on their treatment.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "psychosis", "mesh_term": ["Schizophrenia", "Risperidone"], "id": "NCT00049946"}